Agilent Technologies, Inc.

A

$106.17

+42.15% (1 year change)

Avg closing price

Price range

Market Cap

$32.7 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$1.26 Billion

Total revenue in the last quarter.

Net Income

$199 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$2.23

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.704 (0.66%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

47.52x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$230 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

16,300

The number of full time employees.

Revenue & Earnings

Balance Sheet

Agilent Technologies, Inc.

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

News

Recent Analysis of Environmental Testing Equipment Market | Agilent Technologies, Thermo Fisher Scientific, Waters Corporation and Others.

Recent Analysis of Environmental Testing Equipment Market | Agilent Technologies, Thermo Fisher Scientific, Waters Corporation and Others.

According to Market Study Report, Environmental Testing Equipment Market provides a comprehensive analysis of the Environmental Testing Equipment Market segments, including their dynamics, size, gr...

OpenPR OpenPR, 1 day ago
Human Identification Market 2020-2027: Top Companies, Countries, Applications, Challenges & Opportunities-Thermo Fisher Scientific, QIAGEN, Promega, Agilent Technologies, New England Biolabs

Human Identification Market 2020-2027: Top Companies, Countries, Applications, Challenges & Opportunities-Thermo Fisher Scientific, QIAGEN, Promega, Agilent Technologies, New England Biolabs

A consciously conceived and designed Business Intelligence Report titled Global Human Identification Market Size, Share, Growth, Industry Trends and Forecast to 2027 by Data Bridge Market Research ...

OpenPR OpenPR, 2 days ago
Cancer Diagnostics Market Size, Share and Competitive Analysis: Agilent Technologies, Inc., BD, bioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd

Cancer Diagnostics Market Size, Share and Competitive Analysis: Agilent Technologies, Inc., BD, bioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd

Cancer Diagnostics Market research report helps you grow sales with new thinking, new skills, and innovative programs and tools. A skilled team with expertise solutions and potential capabilities f...

OpenPR OpenPR, 5 days ago